Journal of neurosurgery · 2010 · 42 citations · 28 references
MedicineNeurosurgerySurgeryCerebrovascular NeurosurgeryCerebrovascular SurgeryVascular SurgeryArteriovenous Malformation SurgeryCerebrovascular DiseaseHeadache AssessmentHeadache DisordersHeadache ManagementHeadache PresentationHemorrhage Risk AssessmentIntracranial Vascular MalformationsMultidisciplinary Care PathwaysVisual Function LossVisual Function Measurement
OBJECT: In this study, the authors evaluated how an appropriate allocation of patients with occipital arteriovenous malformations (AVMs) who were treated according to different strategies would affect nonhemorrhagic headache, visual function, and hemorrhage risk levels. METHODS: Of the 712 patients with brain AVMs in the Toronto Western Hospital prospective database, 135 had occipital AVMs. The treatment decision was based on patients' characteristics, presentation, and morphology of the AVM. The management modalities were correlated with their outcomes. RESULTS: The mean follow-up period was 6.78 years. Nonhemorrhagic headache was the most frequent symptom (82 [61%] of 135 patients). Ninety-four patients underwent treatment with one or a combination of embolization, surgery, or radiosurgery, and 41 were simply observed. Of the 40 nontreated patients with nonhemorrhagic headache, only 12 (30%) showed improvement. In the observation group 2 patients (22%) had worsening of visual symptoms, and 2 experienced hemorrhage, for an annual hemorrhage rate of 0.7% per year; 1 patient died. In the treatment group, the improvement in nonhemorrhagic headache in 35 patients (83%) was significant (p < 0.0001). Visual deficit at presentation worsened in 2 (8%), and there were 8 new visual field deficits (9%). The visual worsening was not significantly different. There were 2 other neurological deficits (2%) and 2 deaths (2%) related to the AVM treatment. One AVM hemorrhaged. The annual hemorrhage rate was 0.1% per year. The hemorrhage risk in the observation and treatment groups was lower than the observed hemorrhage risk of all patients with AVMs (4.6%) at the authors' institution. CONCLUSIONS: Appropriate selection of patients with occipital AVMs for one or a combination of treatment modalities yields a significant decrease in nonhemorrhagic headache without significant visual worsening. The multidisciplinary care of occipital AVMs can aim for an apparent decrease in hemorrhage risk.
28
A proposed grading system for arteriovenous malformations
Robert F. Spetzler, Neil A. Martin · Journal of neurosurgery · 1986 · 2.5K citations
Medicine, Neurosurgery, Surgery +10
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation
Christian Stapf, Henning Mast, Robert R. Sciacca et al. · Neurology · 2006 · 784 citations
Medicine, Neurosurgery, Surgery +12
Clinical outcome of radiosurgery for cerebral arteriovenous malformations
Ladislau Steiner, Christer Lindquist, John R. Adler et al. · Journal of neurosurgery · 1992 · 613 citations
Medicine, Neurosurgery, Surgery +9